Insider Monkey • 29 days ago
It seems that the masses and most of the financial media hate hedge funds and what they do, but why is this hatred of hedge funds so prominent? At the end of the day, these asset management firms do not gamble the hard-earned money of the people who are on the edge of poverty. Truth […]
American City Business Journals • 2 months ago
Osiris Therapeutics Inc. stock soared more than 20 percent Tuesday morning after it gave the first glimpse into its balance sheet since last year. The publicly traded Columbia biotech has not filed a financial report since last November, when it reported a $685,000 loss in the third quarter of 2015. Osiris began reviewing its 2014 and 2015 financial statements after its auditor resigned last December.
optionMONSTER • 3 months ago
A trader is preparing for more downside potential in Osiris Therapeutics. OptionMonster's monitoring system detected the purchase of 2,000 February 4 puts for $0.60 at the same time yesterday. This is ...
Insider Monkey • 3 months ago
Osiris Therapeutics, Inc. (NASDAQ:OSIR) took it on the chin yesterday morning after the company released news through an 8-K filing. Today, we’ll talk about that news, what we’re currently seeing from the stock, and what we can expect to see from OSIR ahead. OSIR Announces Enrollment Termination Through 8-K Filing While most big news is […]
Yahoo Finance • 8 months ago
Stocks trim gains for the month of May as strong data has traders eying the Fed. Could this week job's report push the Fed over the rate hike edge? Catch The Final Round at 4p ET with Jen Rogers and markets correspondent Nicole Sinclair.
24/7 Wall St. • 10 months ago
March 9, 2016: Here are four stocks trading with heavy volume among 26 equities making new 52-week lows in Wednesday’s session. Unisys Corp. (NYSE: UIS) fell by nearly 28% on Wednesday to post a new 52-week ...
Investopedia • 11 months ago
Discover some of the most promising micro-cap biotechnology stocks that investors can consider for their 2016 investment portfolio.
OSIR : Summary for Osiris Therapeutics, Inc. - Yahoo Finance
Osiris Therapeutics, Inc. (OSIR)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
|Day's Range||4.87 - 5.00|
|52 Week Range||3.55 - 7.87|
|PE Ratio (TTM)||116.90|
|Earnings Date||Mar 23, 2016 - Mar 24, 2016|
|Dividend & Yield||0.00 (0.00%)|
|1y Target Est||4.00|